Posts

STAT+: Up and down the ladder: The latest comings and g...

From new hires to departures, promotions, and transfers, here are the latest com...

STAT+: Pharmalittle: Sanofi cuts price on a popular ins...

FDA Commissioner Robert Califf wants private insurers to chip in on doing post-a...

JAMA’s new editor settles in, bringing open access and ...

STAT sat down with Kirsten Bibbins-Domingo to learn more about the changes she’s...

STAT+: To prevent emergency C-sections, researchers tur...

Researchers want to use AI to better predict the need for C-sections — and give ...

Opinion: The staggering financial burden of a proposed ...

The already beleaguered U.S. health care system is facing a new and costly threa...

Polio cases derived from new oral vaccine reported for ...

Experts have long understood that a new polio vaccine developed to try to minimi...

STAT+: Federal Medicaid officials cajole states to auto...

Medicaid officials are working unusually closely with states as the pandemic-era...

STAT+: FDA to convene advisory panel for Sarepta’s gene...

In a sudden about-face, the Food and Drug Administration will hold a meeting of ...

STAT+: Sanofi becomes the third leading insulin maker t...

Sanofi has become the latest insulin maker to cut list prices in response to mou...

Listen: SVB’s long biotech shadow, pushy AI algorithms,...

Is AI dictating patient care? What happens when your bank falls apart? And can I...

STAT+: Here’s why there aren’t many cheap, generic vers...

“This could make it easier for generic firms to circumvent device patents on inh...

STAT+: Califf criticizes insurers for doing too little ...

The FDA chief wants insurers to help with drug research. It’s a new request for ...

U.S. pregnancy deaths dropped in 2022, after Covid spike

Deaths of pregnant women in the U.S. fell in 2022, dropping significantly from a...

Large network of clinics offering ketamine for depressi...

One of the largest operators of ketamine clinics in the country abruptly closed ...

STAT+: Pharmalittle: Alzheimer’s group starts lobbying ...

The federal judge who could upend access to an abortion medication pressed gover...

STAT+: U.K. trade group suspends Novo Nordisk for ‘seri...

A U.K. pharmaceutical industry trade group suspended Novo Nordisk for two years ...